W
ONC

WealthCollab’s BeOne Medicines Ltd ONC Stock Holding History

WealthCollab’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.27K Hold
11
– – ﹤0.01% 768
2025
Q4 		$3.34K Hold
11
– – ﹤0.01% 804
2025
Q3 		$3.75K Hold
11
– – ﹤0.01% 730
2025
Q2 		$2.66K Buy
+11
New +$2.7K ﹤0.01% 771

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

WealthCollab's ONC Position: Q1 2026 in Review

WealthCollab held its BeOne Medicines Ltd (ONC) position steady in Q1 2026 at 11 shares worth $3.27K. The position accounts for ﹤0.01% of the portfolio, ranked #768.

WealthCollab first reported a position in ONC in Q2 2025 and has held it in 4 quarters since. The position peaked at $3.75K in Q3 2025. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • WealthCollab held 11 shares of BeOne Medicines Ltd worth $3.27K as of Q1 2026.
  • WealthCollab left its BeOne Medicines Ltd share count unchanged in Q1 2026.
  • BeOne Medicines Ltd made up ﹤0.01% of WealthCollab's portfolio in Q1 2026, its #768 holding.
  • WealthCollab first reported a position in BeOne Medicines Ltd in Q2 2025 and has held it in 4 quarters since.
  • WealthCollab's BeOne Medicines Ltd position peaked at $3.75K in Q3 2025.
  • 281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on WealthCollab's 13F filing for Q1 2026, filed 13 May 2026.